Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is a vertically-integrated developer and manufacturer of generic and specialty pharmaceutical products. Co-founded by Chirag and Chintu Patel in 2002, Amneal was privately-held for the first 15 years of its history. Over that period, the company invested extensively in R&D resources, manufacturing infrastructure and front-end distribution, growing revenue to over $1 billion. In May 2018, Amneal completed an all-equity business combination with Impax Laboratories, Inc. (formerly NYSE: IPXL). The transaction created the 5th largest U.S. generic drug company and gave Amneal an entree to the high-margin specialty pharma business. Upon close of the transaction, the combined entity began trading on the New York Stock Exchange under the ticker AMRX.

This website uses cookies to ensure you get the best experience on our website.